Travoprost Ophthalmic Topical Cream mid-dose

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular HypertensionNCT06152861Glaukos CorporationPhase 2Unknown2024-08Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.